Home

Syngene International Ltd PE Ratio

Image

Syngene International Ltd

NSE: SYNGENE

PE

59.8

Last updated on: Feb 13, 2025

Key Highlights

  • The P/E Ratio of Syngene International Ltd is 59.8 as of 13 Feb 11:34 AM .
  • The P/E Ratio of Syngene International Ltd changed from 23.5 on March 2020 to 55.3 on March 2024 . This represents a CAGR of 18.67% over 5 years.
  • The Latest Trading Price of Syngene International Ltd is ₹ 709.95 as of 13 Feb 11:27 .
  • The PE Ratio of Healthcare Industry has changed from 35.5 to 62.3 in 5 years. This represents a CAGR of 11.91%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of Healthcare industry is 62.3. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Syngene International Ltd

No data available

Company Fundamentals for Syngene International Ltd

Image

Syngene International Ltd

NSE: SYNGENE

Share Price

₹ 709.95

0.40 (0.06%)

stock direction

Last updated on: Feb 13, 2025

Market Price of Syngene International Ltd

1M

1Y

3Y

5Y

Monitoring Syngene International Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 Feb 2025709.55
11 Feb 2025723.25
10 Feb 2025736.2
07 Feb 2025745.15
06 Feb 2025745.7
05 Feb 2025746.75
04 Feb 2025739.9
03 Feb 2025741.3
01 Feb 2025738.7
31 Jan 2025747

SWOT Analysis Of Syngene International Ltd

Strength

2

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Syngene International Ltd

Asset Value vs Market Value of Syngene International Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Syngene International Ltd28562
Max Healthcare Institute Ltd97627
Apollo Hospitals Enterprise Ltd91651
Fortis Healthcare Ltd46437
Global Health Ltd29269
Narayana Hrudayalaya Ltd28208

PE Ratio of Syngene International Ltd Explained

28562

Market cap

501

Earnings

59.8X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Healthcare Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Syngene International Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Syngene International Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Syngene International Ltd

No data available

* All values are in %

About Syngene International Ltd

  • Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors.
  • Headquartered in India, the operations are driven by its highly qualified teams comprising ~6000 scientists and its state-of-the-art facilities, spread over 2.2 million sq. ft., across 3 locations in India: Bangalore, Hyderabad and Mangalore.
  • The Company operate into 4 business divisions comprising of Discovery Services, Development Services, Manufacturing Services and the Dedicated Centers. The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited.
  • The Company's health-related services extend across all major therapeutic areas and modalities.

Syngene International Ltd News Hub

Syngene International to convene board meeting

Syngene International will hold a meeting of the Board of Directors of the Company on 23 October 202

Read more

05 Oct 24

Syngene International consolidated net profit declines 8.93% in the September 2024 quarter

Net profit of Syngene International declined 8.93% to Rs 106.10 crore in the quarter ended September

Read more

23 Oct 24

Board of Syngene International approves change in management

The Board of Syngene International at its meeting held on 23 October 2024 has approved the following

Read more

23 Oct 24

Syngene Intl drops after revising FY25 revenue guidance; Q3 PAT jumps 17% YoY

The company reported 17.58% increase in consolidated net profit to Rs 131.1 crore in Q3 FY25 as comp

Read more

24 Jan 25

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Syngene International Ltd

What is the current PE Ratio of Syngene International Ltd?

The Current PE Ratio of Syngene International Ltd is 59.83 as on 13 Feb 2025.

What is the average PE Ratio of the Healthcare industry?

The average industry PE Ratio of Healthcare is 62.3 as on 13 Feb 2025.

What was the PE Ratio of Syngene International Ltd last year?

The PE Ratio of Syngene International Ltd was 51.39 last year, now the PE ratio is 59.83, showing a year-on-year growth of 16.4%.

What does the PE Ratio of Syngene International Ltd indicate about its stock?

The PE Ratio of Syngene International Ltd is 59.83. This ratio indicates that investors are willing to pay 59.83 times the earnings per share for each share of Syngene International Ltd.

What is the PE Ratio Growth of Syngene International Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Syngene International Ltd grew by 16.4% whereas, the EPS ratio grew by 23.9.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions